The Effectiveness of Vestibulectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00873301
Recruitment Status : Completed
First Posted : April 1, 2009
Last Update Posted : April 2, 2012
Information provided by (Responsible Party):
Prof. Jacob Bornstein, Western Galilee Hospital-Nahariya

Brief Summary:
Women with vulvodynia will fill out a questionnaire and undergo a gynecological examination before and 6 months after vestibulectomy. The investigators hypothesize that pain will decrease.

Condition or disease Intervention/treatment Phase
Vulvodynia Procedure: vestibulectomy Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : January 2009
Actual Primary Completion Date : January 2012
Actual Study Completion Date : February 2012

Arm Intervention/treatment
Experimental: vulvodynia Procedure: vestibulectomy
Evaluation of the outcome of vestibulectomy which is the treatment of vulvar vestibulitis

Primary Outcome Measures :
  1. pain [ Time Frame: 6 months following surgery ]

Secondary Outcome Measures :
  1. sexual function [ Time Frame: 6 months afater surgery ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • vulvodynia, scheduled for vestibulectomy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00873301

Western Galilee Hospital- Nahariya
Nahariya, Israel, 22100
Sponsors and Collaborators
Western Galilee Hospital-Nahariya

Responsible Party: Prof. Jacob Bornstein, Chairman, Obstetrics and Gynecology, Western Galilee Hospital-Nahariya Identifier: NCT00873301     History of Changes
Other Study ID Numbers: JB 13-08-2008
First Posted: April 1, 2009    Key Record Dates
Last Update Posted: April 2, 2012
Last Verified: March 2012

Keywords provided by Prof. Jacob Bornstein, Western Galilee Hospital-Nahariya:

Additional relevant MeSH terms:
Vulvar Diseases
Genital Diseases, Female